These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9369958)

  • 1. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
    Piek E; Franzén P; Heldin CH; ten Dijke P
    J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes.
    Marra F; Bonewald LF; Park-Snyder S; Park IS; Woodruff KA; Abboud HE
    J Cell Physiol; 1996 Mar; 166(3):537-46. PubMed ID: 8600157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1.
    Pedrozo HA; Schwartz Z; Gomez R; Ornoy A; Xin-Sheng W; Dallas SL; Bonewald LF; Dean DD; Boyan BD
    J Cell Physiol; 1998 Nov; 177(2):343-54. PubMed ID: 9766531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
    Tam BY; Philip A
    J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
    Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.
    Whitson RH; Wong WL; Itakura K
    J Cell Biochem; 1991 Sep; 47(1):31-42. PubMed ID: 1658013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation.
    Perlman R; Schiemann WP; Brooks MW; Lodish HF; Weinberg RA
    Nat Cell Biol; 2001 Aug; 3(8):708-14. PubMed ID: 11483955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
    Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
    Serrero G; Zhou J; Mills D; LePak N
    J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
    J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells.
    Mitchell EJ; Fitz-Gibbon L; O'Connor-McCourt MD
    J Cell Physiol; 1992 Feb; 150(2):334-43. PubMed ID: 1310325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
    Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
    Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
    Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
    J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
    Arandjelovic S; Freed TA; Gonias SL
    Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.